Researchers from the Philadelphia-based group launched a study to determine if exiting the program led to a drop in the quality of care. The study is featured in the July 2022 edition of The Journal of Arthroplasty.
Four notes:
1. Researchers compared 2,737 primary total knee replacement and 2,009 primary total hip replacement cases from Jan. 1, 2020, to March 30, 2021, after Rothman’s withdrawal from BPCI-A) to 1,203 total knee replacement and 1,088 total hip replacement cases from Oct. 1, 2018, to Aug. 2, 2019, in BPCI-A.
2. Patient demographics, comorbidities, discharge disposition, complications and 90-day readmissions were examined. Multivariate analysis was performed to determine if bundle participation was associated with complications or readmissions.
3. Three study findings:
– Post-bundle total knee replacement patients had a shorter length of stay (1.4 days vs. 1.8 days).
– Both total knee replacement (5.6 percent vs. 19.2 percent) and total hip replacement (6 percent vs. 10 percent) patients were significantly less likely to be discharged to a rehabilitation facility.
– Post-bundle total knee replacement patients had lower complications but saw no difference in 90-day readmission.
4. The study found Rothman has maintained high-quality total hip replacement care and reduced complications and length of stay in total knee replacement under the fee-for-service model. Researchers advised CMS to partner with high-performing orthopedic practices to develop new models for risk sharing.
Read more about the study here.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
